Reach your audience. Get results.
Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.
Public RelationsMaximize the reach of your news with our press release distribution services and partnerships. Investor RelationsReach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools. Distribution & AnalyticsTarget your news, reach your audiences, and understand the impact of your press releases with our analytics reports. |
Latest News
Today is June 10, 2024.
All times in Eastern Daylight Time.
-
Milliman abre un Centro de Excelencia en Modelización en MadridMADRID--(BUSINESS WIRE)--Milliman Inc., una de las principales firmas internacionales de consultoría actuarial, anunció hoy la creación de un Centro de Excelencia en Modelización en Madrid. Este ce... more »
-
QAD dévoile des capacités révolutionnaires de classification par IA au Gartner® Supply Chain Symposium/Xpo™ 2024BARCELONE--(BUSINESS WIRE)--QAD Inc., éditeur de solutions cloud de pilotage de la fabrication et de la supply chain, a annoncé aujourd'hui de nouvelles fonctionnalités pour sa solution Import Mana... more »
-
QAD kündigt neue KI-Klassifizierungsfunktionen auf dem Gartner® Supply Chain Symposium/Xpo™ 2024 anBARCELONA--(BUSINESS WIRE)--QAD Inc., ein führender Anbieter von Cloud-basierten Fertigungs- und Lieferkettenlösungen der nächsten Generation, gab heute auf dem Gartner Supply Chain Symposium/Xpo 2... more »
-
Medincell Publishes Its Consolidated Annual Financial ResultsMONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Medincell (Paris:MEDCL): Highlights Commercial launch by Teva Pharmaceuticals (“Teva”) of UZEDY® (risperidone) in the U.S., the first product ... more »
-
Medincell publie ses résultats financiers annuels consolidésMONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Medincell (Paris:MEDCL): Faits marquants Lancement de la commercialisation aux Etats-Unis de UZEDY® (rispéridone) par Teva Pharmaceuticals ("T... more »
-
4Moving Biotech announces successful results from its Lasare Phase I 4P004 Clinical Trial intraarticular Liraglutide for knee osteoarthritis patientsLILLE, France & PARIS--(BUSINESS WIRE)--4Moving Biotech announces successful results from its Lasare Phase I 4P004 Clinical Trial intraarticular Liraglutide for knee osteoarthritis patients more »
-
4Moving Biotech annonce des résultats positifs pour son essai clinique de Phase I Lasare 4P004 liraglutide intra-articulaire sur des patients souffrants d'arthrose du genouLILLE, France & PARIS--(BUSINESS WIRE)--4Moving Biotech, une filiale de 4P-Pharma, spécialisée dans le développement de traitements de pointe pour soigner l'arthrose du genou, annonce le succès de ... more »
-
e.l.f. SKIN Debuts “Peculiar Behavior” Campaign Starring Jameela Jamil as Highly Requested Bronzing Drops Land at Retailers GloballyOAKLAND, Calif.--(BUSINESS WIRE)--e.l.f. SKIN’s Bronzing Drops - a nourishing tinted serum that gives skin a sun-kissed glow - have dropped, and the brand is launching the long-anticipated product ... more »
-
Loomis Sayles Sustainable Euro Credit fonds bereikt driejarige mijlpaalUTRECHT, Nederland--(BUSINESS WIRE)--Loomis, Sayles & Company, de internationale investeringenbeheerder met EUR320 miljard aan activa onder beheer op 31 maart 2024, en een Natixis Investment Ma... more »
-
Dongfeng Algeria Head Office Opened, Making New Progress in Opening up the African MarketALGIERS, Algeria--(BUSINESS WIRE)--On May 20th, Ma Lei, Managing Director of Dongfeng Motor Corporation International Business Department and China Dongfeng Motor Industry Imp. & Exp. Co., Ltd.... more »
-
Mitsubishi Electric Ships Two New SBD-embedded SiC-MOSFET ModulesTOKYO--(BUSINESS WIRE)--Mitsubishi Electric Corporation (TOKYO: 6503) announced today that it has begun shipping low-current 3.3kV/400A and 3.3kV/200A versions of a Schottky barrier diode (SBD) emb... more »
-
BEIJING--(BUSINESS WIRE)--HAO has established a dedicated service team, collaborating closely with medical aid organizations to assess frontline medical supply requirements. more »
-
LONDON--(BUSINESS WIRE)--Palliser Capital (“Palliser”), the sixth largest shareholder of Keisei Electric Railway Co., Ltd. (9009 JT) (“Keisei” or the “Company”) with a stake of 1.98%, welcomes Glas... more »
-
ロンドン--(BUSINESS WIRE)--(ビジネスワイヤ) -- 京成電鉄株式会社(9009 JT)(以下「京成電鉄」)の第6位株主であり、同社普通株式を1.98%保有するパリサー・キャピタル(以下「パリサー」「当社」、本社:英ロンドン)は、当社株主提案に対するグラス・ルイスの支持を歓迎します。 パリサーの提案は、京成電鉄に対して資本配分政策を策定し、OLC持分を約2年以内に15%未満... more »
-
Unite a Team of Heroes to Defeat Rampaging Elven Gods in Dragon Age™: The Veilguard Arriving in Fall 2024REDWOOD CITY, Calif.--(BUSINESS WIRE)--Cinematic trailer showcasing new cast of companions for Dragon Age: The Veilguard, an all-new single-player fantasy RPG experience coming Fall 2024. more »